Your browser doesn't support javascript.
loading
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.
El Haddad, Lynn; Ariza-Heredia, Ella; Shah, Dimpy P; Jiang, Ying; Blanchard, Ted; Ghantoji, Shashank S; El Chaer, Firas; El-Haddad, Danielle; Prayag, Amrita; Nesher, Lior; Rezvani, Katy; Shpall, Elizabeth; Chemaly, Roy F.
Afiliação
  • El Haddad L; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Ariza-Heredia E; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Shah DP; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Jiang Y; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Blanchard T; Oxford Immunotec Incorporation, Marlborough, Massachusetts.
  • Ghantoji SS; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • El Chaer F; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • El-Haddad D; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Prayag A; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Nesher L; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
  • Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Shpall E; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston.
  • Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston.
J Infect Dis ; 219(6): 898-907, 2019 02 23.
Article em En | MEDLINE | ID: mdl-30295846
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Citomegalovirus / ELISPOT Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Citomegalovirus / ELISPOT Idioma: En Ano de publicação: 2019 Tipo de documento: Article